In this Hot Topics in IPC, Saskia v. Popescu, PhD, MPH, MA, CIC, FAPIC, discusses COVID-19 vaccines and boosters, Legionella infections from transplants, and hospital leadership.
New COVID-19 Vaccine Recommendations and an Updated Booster!
Good news – as we’re about to start heading into the winter months and concerns regarding a winter surge are increasing, like the cases of COVID-19 in the community, we have a new tool in the arsenal. Updated booster shots will soon be available from Moderna and Pfizer after receiving Food & Drug Administration approval. The CDC has also updated its recommendations to include “CDC recommends everyone 6 months and older get an updated COVID-19 vaccine to protect against the potentially serious outcomes of COVID-19 illness this fall and winter.” The CDC also notes that “If you have not received a COVID-19 vaccine in the past 2 months, get an updated COVID-19 vaccine to protect yourself this fall and winter.” We’ll likely see these new boosters rolled out in the next week or so, which will give us time to remind our health care workers, patients, and visitors of the importance of staying up to date and doing so now before winter hits.
Transplant-Associated Legionella Infection?
This wasn’t something I had on my 2023 Bingo card, but here we are. The CDC just released a new Morbidity and Mortality Weekly Report discussing two cases of Legionnaires disease in recipients of lung transplants from a single donor in 2022. The report does note the evaluation of such an unusual case, “The donor’s cause of death was freshwater drowning in a river, raising suspicion of potential donor-derived transmission because Legionella bacteria naturally live in fresh water. Further investigation of patients receiving other organs from the same donor did not identify additional legionellosis cases. Health care–associated infection caused by water exposure at the hospital was also evaluated as a potential source of infection and was found to be unlikely. Hospital water quality parameter measurements collected during May–June 2022 were within expected ranges, and no water disruptions were noted, although no testing for Legionella was performed during this period.”
Hospital Leadership Support is A Big Deal
Perhaps an obvious statement, but nonetheless, a new article is calling out the importance of hospital leadership support for infection prevention and control departments and programs. In this survey, the research team assessed infection preventionists’ experiences and perceptions of hospital leadership support of their programs during the COVID-19 pandemic and the relative impact on burnout. The research team noted, “64% reported very good to excellent hospital leadership support for their infection prevention and control program. However, 49% reported feeling burned out from their work. Also, [approximately] 30% responded positively [to] for all 7 psychological safety questions and were deemed to have “high psychological safety,” and 76% responded positively to the 2 safety climate questions and were deemed to have a “high safety climate.” Our results indicate an association between strong hospital leadership support and lower burnout (IRR, 0.61; 95% CI, 0.50–0.74), higher perceptions of psychological safety.” This could be a helpful article to share with your hospital leadership in that their efforts, support, and overall enthusiasm for IPC efforts truly make a difference in not only the department and program but also the individuals who are in the trenches.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
Managing Multimorbidity and Polypharmacy in HIV: Insights From Michelle S. Cespedes, MD, MS
November 20th 2024Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.
Longhorn Vaccines and Diagnostics to Showcase Breakthrough Vaccine Data at IDWeek 2024
November 19th 2024Longhorn Vaccines and Diagnostics revealed promising data on universal influenza vaccine LHNVD-110 and AMR sepsis vaccine LHNVD-303 at IDWeek 2024, addressing critical global health challenges.
Infection Intel: Revolutionizing Ultrasound Probe Disinfection With Germitec's Chronos
November 19th 2024Learn how Germitec’s Chronos uses patented UV-C technology for high-level disinfection of ultrasound probes in 90 seconds, enhancing infection control, patient safety, and environmental sustainability.
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies